There is Opportunity to Alembic Pharma, because quarterly results are showing good. Consolidated profits of the company have increased from Rs 131 crore to Rs 170 crore. Consolidated income has also increased from Rs 840 crore to Rs 1018 crores. Speaking of margins, it has increased from 22.3 percent to 23.8 percent.
Alembic Pharmaceuticals Ltd surged around 1 percent at Rs 593 in NSE. On the NSE 168 lac shares were traded on the counter so far as against the average daily volumes of 28130.
Advice for Intraday Trading
Buy Alembic Pharma (APLLTD) for Intraday above 593 for Targets 598, 604 put Stop Loss 587.
Short Term Investment Ideas Alembic Pharma
Short Term Investors Can Buy APLLTD Shares 500 to 1000 above 590 for targets 615, 625 Put Stop Loss 573.
Learn,,, Best Trading Strategy